Literature DB >> 6641914

Liver lectins: mediators for metastases?

G Uhlenbruck, J Beuth, V Weidtman.   

Abstract

Development of liver metastases in 1542 cancer patients was investigated. It was found that in certain liver diseases the incidence of liver metastases was reduced compared to that in cancer patients with otherwise normal livers. We propose that this reduction may be due to a reduced function of the liver-specific lectins.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6641914     DOI： 10.1007/BF01990389

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  9 in total

Review 1.  [Immunobiology of neuraminic acid: a contribution to the antigenicity of brain tumors].

Authors:  G Uhlenbruck; W Gielen
Journal:  Fortschr Neurol Psychiatr Grenzgeb       Date:  1970-04

Review 2.  Hepatic clearance of serum glycoproteins.

Authors:  I G McFarlane
Journal:  Clin Sci (Lond)       Date:  1983-02       Impact factor: 6.124

Review 3.  Carbohydrate-specific receptors of the liver.

Authors:  G Ashwell; J Harford
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

Review 4.  The Thomsen-Friedenreich (TF) receptor: an old history with new mystery.

Authors:  G Uhlenbruck
Journal:  Immunol Commun       Date:  1981

5.  Blood group MN precursors as human breast carcinoma-associated antigens and "naturally" occurring human cytotoxins against them.

Authors:  G F Springer; P R Desai; E F Scanlon
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

6.  The presence and significance of the Thomsen-Friedenreich antigen in breast cancer. I. Serological studies.

Authors:  R A Newman; P J Klein; G Uhlenbruck; P Citoler; D Karduck
Journal:  J Cancer Res Clin Oncol       Date:  1979-02-19       Impact factor: 4.553

7.  Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage.

Authors:  J S Marshall; A M Green; J Pensky; S Williams; A Zinn; D M Carlson
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

8.  Studies on the fate of defined asialoglycoproteins in the circulation of the mouse.

Authors:  R A Newman; U Fricke; P J Klein; G Uhlenbruck; A L De Vries
Journal:  J Clin Chem Clin Biochem       Date:  1980-01

9.  Hepatocyte-tumor cell interaction in vitro. I. Conditions for rosette formation and inhibition by anti-H-2 antibody.

Authors:  V Schirrmacher; R Cheingsong-Popov; H Arnheiter
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307
  9 in total
  7 in total

1.  Inhibition of liver tumor cell colonization in two animal tumor models by lectin blocking with D-galactose or arabinogalactan.

Authors:  J Beuth; H L Ko; V Schirrmacher; G Uhlenbruck; G Pulverer
Journal:  Clin Exp Metastasis       Date:  1988 Mar-Apr       Impact factor: 5.150

2.  Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose.

Authors:  J Beuth; H L Ko; K Oette; G Pulverer; K Roszkowski; G Uhlenbruck
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 3.  Importance of lectins for the prevention of bacterial infections and cancer metastases.

Authors:  J Beuth; H L Ko; G Pulverer; G Uhlenbruck; H Pichlmaier
Journal:  Glycoconj J       Date:  1995-02       Impact factor: 2.916

4.  In vitro and in vivo inhibition of lectin mediated adhesion of Pseudomonas aeruginosa by receptor blocking carbohydrates.

Authors:  H L Ko; J Beuth; J Sölter; H Schroten; G Uhlenbruck; G Pulverer
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

5.  Hepatocellular injury inhibits lectin-mediated tumor colonization into BALB/c-mice livers.

Authors:  J Beuth; H L Ko; M Steuer; G Pulverer
Journal:  Experientia       Date:  1993-07-05

6.  Prevention of experimental liver metastases by D-galactose.

Authors:  G Uhlenbruck; J Beuth; K Oette; H L Ko; G Pulverer
Journal:  Experientia       Date:  1987-04-15

7.  Glycosphingolipid expression on murine L1-fibrosarcoma cells: analysis of clonal in vivo and in vitro selected sublines with different lung colonisation potential.

Authors:  F G Hanisch; J Sölter; V Jansen; A Lochner; J Peter-Katalinic; G Uhlenbruck
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.